Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Hyperkalemia | Research

Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients

Authors: Lila Bouadma, Stefan Mankikian, Michael Darmon, Laurent Argaud, Camille Vinclair, Shidasp Siami, Maité Garrouste-Orgeas, Laurent Papazian, Yves Cohen, Guillaume Marcotte, Lenka Styfalova, Jean Reignier, Alexandre Lautrette, Carole Schwebel, Jean-Francois Timsit, on behalf of the OUTCOMEREA STUDY GROUP

Published in: Critical Care | Issue 1/2019

Login to get access

Abstract

Objectives

Our objectives were (1) to characterize the distribution of serum potassium levels at ICU admission, (2) to examine the relationship between dyskalemia at ICU admission and occurrence of cardiac events, and (3) to study both the association between dyskalemia at ICU admission and dyskalemia correction by day 2 on 28-day mortality.

Design

Inception cohort study from the longitudinal prospective French multicenter OUTCOMEREA database (1999–2014)

Setting

22 French OUTCOMEREA network ICUs

Patients

Patients were classified into six groups according to their serum potassium level at admission: three groups of hypokalemia and three groups of hyperkalemia defined as serious hypokalemia [K+] < 2.5 and serious hyperkalemia [K+] > 7 mmol/L, moderate hypokalemia 2.5 ≤ [K+] < 3 mmol/L and moderate hyperkalemia 6 < [K+] ≤ 7 mmol/L, and mild hypokalemia 3 ≤ [K+] < 3.5 mmol/L and mild hyperkalemia 5 < [K+] ≤ 6 mmol/L. We sorted evolution at day 2 of dyskalemia into three categories: balanced, not-balanced, and overbalanced.

Intervention

None

Measurements and main results

Of 12,090 patients, 2108 (17.4%) had hypokalemia and 1445 (12%) had hyperkalemia.
Prognostic impact of dyskalemia and its correction was assessed using multivariate Cox models. After adjustment, hypokalemia and hyperkalemia were independently associated with a greater risk of 28-day mortality. Mild hyperkalemic patients had the highest mortality (hazard ratio (HR) 1.29, 95% confidence interval (CI) [1.13–1.47], p < 0.001). Adjusted 28-day mortality was higher if serum potassium level was not-balanced at day 2 (aHR = 1.51, 95% CI [1.30–1.76], p < 0.0001) and numerically higher but not significantly different if serum potassium level was overbalanced at day 2 (aHR = 1.157, 95% CI [0.84–1.60], p = 0.38). Occurrence of cardiac events was evaluated by logistic regression. Except for patients with serious hypokalemia at admission, the depth of dyskalemia was associated with increased risk of cardiac events.

Conclusions

Dyskalemia is common at ICU admission and associated with increased mortality. Occurrence of cardiac events increased with dyskalemia depth. A correction of serum potassium level by day 2 was associated with improved prognosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004;43:155–61.CrossRef Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004;43:155–61.CrossRef
2.
go back to reference Goyal A, Spertus JA, Gosch K, et al. SErum potassium levels and mortality in acute myocardial infarction. JAMA. 2012;307:157–64.CrossRef Goyal A, Spertus JA, Gosch K, et al. SErum potassium levels and mortality in acute myocardial infarction. JAMA. 2012;307:157–64.CrossRef
3.
go back to reference Le Gall J, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63.CrossRef Le Gall J, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63.CrossRef
4.
go back to reference McMahon GM, Mendu ML, Gibbons FK, et al. Association between hyperkalemia at critical care initiation and mortality. Intensive Care Med. 2012;38:1834–42.CrossRef McMahon GM, Mendu ML, Gibbons FK, et al. Association between hyperkalemia at critical care initiation and mortality. Intensive Care Med. 2012;38:1834–42.CrossRef
5.
go back to reference Darmon M, Timsit JF, Francais A, Nguile-Makao M, Adrie C, Cohen Y, Garrouste-Orgeas M, Goldgran-Toledano D, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Souweine B, Azoulay E. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant. 2010;25(8):2510–5.CrossRef Darmon M, Timsit JF, Francais A, Nguile-Makao M, Adrie C, Cohen Y, Garrouste-Orgeas M, Goldgran-Toledano D, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Souweine B, Azoulay E. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant. 2010;25(8):2510–5.CrossRef
6.
go back to reference Darmon M, Pichon M, Schwebel C, et al. Influence of early dysnatremia correction on survival of critically ill patients. Shock. 2014;41:394–9.CrossRef Darmon M, Pichon M, Schwebel C, et al. Influence of early dysnatremia correction on survival of critically ill patients. Shock. 2014;41:394–9.CrossRef
7.
go back to reference Darmon M, Diconne E, Souweine B, et al. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care. 2013;17:R12.CrossRef Darmon M, Diconne E, Souweine B, et al. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care. 2013;17:R12.CrossRef
8.
go back to reference Francais A, Vesin A, Timsit J-F. How to conduct clinical research studies using high quality-clinical databases in the critical care. Rev Bras Ter Intensiva. 2008;20:296–304.CrossRef Francais A, Vesin A, Timsit J-F. How to conduct clinical research studies using high quality-clinical databases in the critical care. Rev Bras Ter Intensiva. 2008;20:296–304.CrossRef
9.
go back to reference Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.CrossRef Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.CrossRef
10.
go back to reference Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9:591–7.CrossRef Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9:591–7.CrossRef
11.
go back to reference Hessels L, Hoekstra M, Mijzen LJ, et al. The relationship between serum potassium, potassium variability and in-hospital mortality in critically ill patients and a before-after analysis on the impact of computer-assisted potassium control. Crit Care Lond Engl. 2015;19:4.CrossRef Hessels L, Hoekstra M, Mijzen LJ, et al. The relationship between serum potassium, potassium variability and in-hospital mortality in critically ill patients and a before-after analysis on the impact of computer-assisted potassium control. Crit Care Lond Engl. 2015;19:4.CrossRef
12.
go back to reference Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–59.CrossRef Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–59.CrossRef
13.
go back to reference Gennari FJ. Disorders of potassium homeostasis. Crit Care Clin. 2002;18:273–88.CrossRef Gennari FJ. Disorders of potassium homeostasis. Crit Care Clin. 2002;18:273–88.CrossRef
14.
go back to reference Henz S, Maeder MT, Huber S, et al. Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrol Dial Transplant. 2008;23:3939–45.CrossRef Henz S, Maeder MT, Huber S, et al. Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrol Dial Transplant. 2008;23:3939–45.CrossRef
16.
go back to reference Kette F, Weil MH, Gazmuri RJ, et al. Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med. 1993;21:901–6.CrossRef Kette F, Weil MH, Gazmuri RJ, et al. Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med. 1993;21:901–6.CrossRef
17.
go back to reference von Planta I, Weil MH, von Planta M, et al. Hypercarbic acidosis reduces cardiac resuscitability. Crit Care Med. 1991;19:1177–82.CrossRef von Planta I, Weil MH, von Planta M, et al. Hypercarbic acidosis reduces cardiac resuscitability. Crit Care Med. 1991;19:1177–82.CrossRef
18.
go back to reference Kuipers S, Klein Klouwenberg PMC, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care Lond Engl. 2014;18:688.CrossRef Kuipers S, Klein Klouwenberg PMC, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care Lond Engl. 2014;18:688.CrossRef
19.
go back to reference van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRef van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRef
20.
go back to reference Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.CrossRef Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.CrossRef
21.
go back to reference NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.CrossRef NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.CrossRef
Metadata
Title
Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients
Authors
Lila Bouadma
Stefan Mankikian
Michael Darmon
Laurent Argaud
Camille Vinclair
Shidasp Siami
Maité Garrouste-Orgeas
Laurent Papazian
Yves Cohen
Guillaume Marcotte
Lenka Styfalova
Jean Reignier
Alexandre Lautrette
Carole Schwebel
Jean-Francois Timsit
on behalf of the OUTCOMEREA STUDY GROUP
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2019
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-019-2679-z

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue